Metagenomi Therapeutics (MGX) Change in Taxes (2023)
Metagenomi Therapeutics (MGX) posted quarterly Change in Taxes of $1.1 million for Q4 2023, up 301.1% quarter-over-quarter from -$546000.0 in Q3 2023.
Metagenomi Therapeutics (MGX) Change in Taxes (2023) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Change in Taxes for 1 consecutive years, with $1.1 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Change in Taxes changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2024 stood at $552000.0 (down 68.09% YoY), while the FY2024 annual figure was -$3.3 million, down 288.79% from the prior year.
- Change in Taxes improved to $1.1 million in Q4 2023 per MGX's latest filing, from -$546000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $1.9 million in Q1 2023 and bottomed at -$759000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Metagenomi Therapeutics | 46.51 Mn | 46.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.10 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | -546,000.00 |
| Sep 30, 2023 | -546,000.00 |
| Jun 30, 2023 | -759,000.00 |
| Jun 30, 2023 | -759,000.00 |
| Mar 31, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.94 Mn |